HRB National Drugs Library e-newsletter volume 18, issue 3

To view our entire collection of research and access our resources visit our website, Ireland's comprehensive substance use research library. And follow us on Twitter @HRBdrugslibrary.
For all recent additions see our recently added publications page.

Irish-related publications

Comparing characteristics of suicide to non-suicide drug poisoning deaths, by sex, in Ireland.

Lynn, Ena and Cousins, Gráinne and Lyons, Suzi and Bennett, Kathleen E (2022) Journal of Affective Disorders, 306. pp. 80-89.

A scoping review of the health impact of the covid-19 pandemic on persons experiencing homelessness in North America and Europe.

Corey, Julia and Lyons, James and O'Carroll, Austin and Stafford, Richie and Ivers, Jo-Hanna (2022) International Journal of Environmental Research and Public Health, 19, (6).

What motivates students to decrease or cease substance use?: A scoping review.

Dockray, S et al (2022) Irish Journal of Psychological Medicine, pp. 1-6.

Responses to the needs of children of people who use drugs. Background paper commissioned by the EMCDDA for Health and social responses to drug problems: a European guide.

Comiskey, Catherine (2019) Lisbon: European Monitoring Centre for Drugs and Drug Addiction.

Associations between mental health, alcohol consumption and drinking motives during COVID-19 second lockdown in Ireland.

Carbia, Carina et al (2022) Alcohol and Alcoholism, 57, (2), pp. 211-218.

Hospital initiation of benzodiazepines and Z-drugs in older adults and discontinuation in primary care.

Coll, Seán et al (2022) Research in Social & Administrative Pharmacy, 18, (4), pp. 2670-2674

Emergency department utilisation by homeless children in Dublin, Ireland: a retrospective review.

O'Brien, Niamh et al (2022) BMJ Paediatrics Open, 6, (1)

One year of psychiatric presentations to a hospital emergency department during COVID-19.

Hartnett, Yvonne et al (2022) Irish Journal of Psychological Medicine, Early online. https://doi.org/10.1017/ipm.2022.6

[Audio] Let’s talk About Recovery. Introduction: what is recovery?

Losty, Sandra and Ivers, Jo-Hanna (2022)

[Audio] Let's talk about recovery. Women and recovery - blocks, barriers and building each other up.

Ivers, Jo-Hanna and Losty, Sandra (2022)

[Audio] Harnessing our health data. If we don't measure it, we can't manage it.

Kabir, Zubair and Doyle, Anne and Graham, Lesley and Jayne, Elinor (2022) Dublin: Alcohol Action Ireland.

[Audio] Conversations on the margins

Ruane, Lynn (2022)

[Video] Consultation on reform of alcohol licencing laws.

(2022) Department of Justice and Equality.

Women’s health action plan 2022—2023. Ireland.

(2022) Dublin: Department of Health.

Suicidal ideation and behaviors among Irish Travellers presenting for emergency care.

Tanner, Bryan and Doherty, Anne M (2022) Crisis, 43, (2), pp. 149-156.

Incidence of self-harm and suicide-related ideation among the Irish Traveller indigenous population presenting to hospital emergency departments: evidence from the National Clinical Programme for Self-Harm.

Kavalidou, Katerina et al (2022) Research Square, Early online. DOI: 10.21203/rs.3.rs-1442634/v1 (In Press)

Exploring serious and organised crime across Ireland and the UK towards a shared understanding of a shared threat.

Chance, Alexander (2022) Dublin: The Azure Forum for Contemporary Security Strategy.

Crime, justice and criminology in the Republic of Ireland.

Hamilton, Claire (2022) European Journal of Criminology, Early online. https://doi.org/10.1177%2F14773708211070215

Prison visiting committee annual reports 2020.

Prison visiting committees (2022) Dublin: Department of Justice and Equality.

Opening statement - pre-legislative scrutiny of the General Scheme of the Gambling Regulation Bill.

McAvoy, Helen and Reynolds, Ciara (2022) Dublin: Institute of Public Health.

Commissioner's monthly reports to Policing Authority.

Office of the Commissioner. McMahon, Anne Marie (2022)

Health & wellbeing key performance indicator metadata 2021.

(2022) Dublin: Health Service Executive

(2022) Belfast: Northern Ireland Statistics and Research Agency.

Use and awareness of heated tobacco products in Europe.

Gallus, Silvano et al (2022) Journal of Epidemiology, 32, (3), pp. 139-144.

Peer-delivery of a gender-specific smoking cessation intervention for women living in disadvantaged communities in Ireland we can Quit2 (WCQ2)-a pilot cluster randomized controlled trial.

Hayes, Catherine B et al (2022) Nicotine & Tobacco Research, 24, (4), pp. 564-573.

International publications

Local communities and drugs: health and social responses.

EMCDDA (2022)

Recreational settings and drugs: health and social responses.

EMCDDA (2022)

Workplaces and drugs: health and social responses.

EMCDDA (2022)

Prevention toolkit.

EMCDDA (2022)

Wastewater analysis and drugs — a European multi-city study.

EMCDDA (2022)

Spotlight on... Drug checking.

EMCDDA (2022)

Report of the International Narcotics Control Board for 2021.

(2022) Vienna: United Nations.

Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances 2021.

International Narcotics Control Board. (2022) Vienna: United Nations.

Proposal for a regulation of the European Parliament and of the Council on the European Union Drugs Agency.

(2022) Brussels: European Commission.

Women in the cocaine supply chain, Cocaine Insights 3.

(2022) Vienna: UNODC.

Burden of non-communicable diseases among adolescents aged 10–24 years in the EU, 1990–2019: a systematic analysis of the Global Burden of Diseases Study 2019.

Armocida, Bernadette et al (2022) The Lancet. Child & Adolescent Health, Early online. https://doi.org/10.1016/S2352-4642(22)00073-6

[Video] NDARC webinar series presentation. Non-opioid prescription misuse - new kids on the block.

Brett, Jonathan (2022) National Drug and Alcohol Research Centre.

Substance use in the transgender population: a meta-analysis.

Cotaina, Miriam et al (2022) Brain Sciences, 12, (3). doi: 10.3390/brainsci12030366

Integrated health and social care for people experiencing homelessness.

National Institute for Health and Care Excellence, Centre for Homelessness Impact. (2022) London: NICE.

Client and practitioner experiences and perceptions of virtual services and supports for substance use or concurrent disorders during the COVID-19 pandemic.

Goodman, A et al (2022) Ottawa: Canadian Centre on Substance Use and Addiction.

20 years of developments in drug use among adolescents in Europe.

Spilka, Stanislas et al (2022) Paris: OFDT

The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.

Schofield, Joe et al (2022) BMC Public Health, 22. doi:10.1186/s12889-022-12873-y

Dipyanone.

Center for Forensic Science Research and Education (2022) Pennsylvania: CFSRE.

The effectiveness of psychosocial interventions at reducing the frequency of alcohol and drug use in parents: findings of a Cochrane Review and meta-analyses.

McGovern, Ruth et al (2022) Addiction, Early online. doi: 10.1111/add.15846

Overcoming the pains of recovery: the management of negative recovery capital during addiction recovery pathways.

Patton, David et al (2022) Addiction Research & Theory, Early online. https://doi.org/10.1080/16066359.2022.2039912

Victimisation and its relationship to drug misuse, common mental disorder and well-being in England and Wales: year ending March 2021.

(2022) London: Office for National Statistics.

Measurement properties of smartphone approaches to assess diet, alcohol use, and tobacco use: systematic review.

Thornton, Louise et al (2022) JMIR mHealth and uHealth, 10, (2), e27337.

Building prevention systems: who are the consumers of prevention and harm reduction services?

APSI Prevention Nuggets (2022) Applied Prevention Science International

Reducing drug deaths in London.

London Assembly Health Committee (2022) The London Assembly.

Risk assessment of new psychoactive substances (NPS).

EMCDDA (2022)

Report on the risk assessment of 1-(3-chlorophenyl)-2-(methylamino)propan-1-one (3-chloromethcathinone, 3-CMC)

EMCDDA (2022) Luxembourg: Publications Office of the European Union.

Report on the risk assessment of 2-(methylamino)-1-(3-methylphenyl)propan-1-one (3-methylmethcathinone, 3-MMC)

EMCDDA (2022) Luxembourg: Publications Office of the European Union.

Substance misuse: providing remote and in-person interventions.

(2022) London: Office for Health Improvement & Disparities.

How traffic law enforcement can contribute to safer roads: PIN flash 42.

(2022) Brussels: European Safety Transport Council.

HIV clinic-based extended-release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non-blinded, randomized non-inferiority trial.

Korthuis, P Todd et al (2022) Addiction, Early online. doi: 10.1111/add.15836

Review of medication-assisted treatment for opioid use disorder.

Ghanem, Nessreen et al (2022) Journal of Osteopathic Medicine, doi: 10.1515/jom-2021-0163

Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study.

Gomes, Tara et al (2022) Addiction, Early online. doi: 10.1111/add.15862

Infrequent detection of unintentional fentanyl use via urinalysis among people who regularly inject opioids in Sydney and Melbourne, Australia.

Lam, Tina et al (2022) Addiction, Early online. doi: 10.1111/add.15832

Simulated cost-effectiveness and long-term clinical outcomes of addiction care and antibiotic therapy strategies for patients with injection drug use-associated infective endocarditis.

Adams, Joëlla W et al (2022) JAMA Network Open, 5, (2).

Overdose prevention centres in the UK

Holland, Adam et al (2022) The Lancet Public Health, 7, (3), e196-e197.

Suspected drug deaths in Scotland: October to December 2021.

(2022) Edinburgh: Scottish Government

Avoidable mortality in Great Britain

(2022) United Kingdom. Office for National Statistics.

The death penalty for drug offences 2021: global overview 2021.

Girelli, Giada and Larasati, Ajeng (2022) London: Harm Reduction International

Expert advice for prescribing cannabis medicines for patients with epilepsy - drawn from the Australian clinical experience.

Lawson, John et al (2022) British Journal of Clinical Pharmacology, Early online. doi: 10.1111/bcp.15262

We need to talk about cannabis dependency.

Glover, Ella (2022) Volteface blog,

The iCannToolkit: a tool to embrace measurement of medicinal and non-medicinal cannabis use across licit, illicit and cross-cultural settings.

Lorenzetti, Valentina et al (2022) Addiction, Early online. doi: 10.1111/add.15855

Effect of medical marijuana card ownership on pain, insomnia, and affective disorder symptoms in adults: a randomized clinical trial.

Gilman, Jodi M et al (2022) JAMA Network Open, 5, (3), e222106.

Cannabis use as a predictor and outcome of positive and negative affect in college students: An ecological momentary assessment study.

Sznitman, Sharon R et al (2022) Addictive Behaviors, 128. doi: 10.1016/j.addbeh.2021.107221

Evaluating the impact of Minimum Unit Pricing (MUP) of alcohol in Scotland on cross-border purchasing.

Chung Patterson, et al (2022) Edinburgh: Public Health Scotland

Association of habitual alcohol intake with risk of cardiovascular disease.

Biddinger, Kiran J et al (2022) JAMA Network Open, 5, (3).

Fetal alcohol spectrum disorder: quality standard.

(2022) London: NICE.

The time is now: the national perspective on ramping up FASD prevention, diagnosis and support services.

(2022) The National Organisation for FASD.

Framework to strengthen implementation of the WHO European Action Plan to Reduce the Harmful Use of Alcohol (EAPA), 2022 – 2025. Draft

(2022) Geneva: World Health Organization Regional Office for Europe.

Exploring the management of alcohol problems in Deep End practices in Scotland.

Mohan, Andrea RM et al (2022) Edinburgh: Scottish Health Action on Alcohol Problems.

Enhanced alcohol container labels: a systematic review.

(2022) Ottawa: Canadian Centre on Substance Use and Addiction.

Associations of alcohol consumption and smoking with disease risk and neurodegeneration in individuals with multiple sclerosis in the United Kingdom.

Kleerekooper, Iris et al (2022) JAMA Network Open, 5, (3).

Trajectories of alcohol consumption in relation to all-cause mortality in patients with cardiovascular disease: a 35-year prospective cohort study.

Ding, Chengyi et al (2022) Addiction, Early online. doi: 10.1111/add.15850

Print and online textual news media coverage of UK low-risk drinking guidelines from 2014 to 2017: a review and thematic analysis.

Kersbergen, Inge et al (2022) Drug and Alcohol Review, Early online. doi: 10.1111/dar.13458

Trends in alcohol consumption in relation to the COVID-19 pandemic: a cross-country analysis.

Plata, Alejandro et al (2022) International Journal of Gastronomy and Food Science, 27. doi: 10.1016/j.ijgfs.2021.100397

Associations between alcohol consumption and gray and white matter volumes in the UK Biobank.

Daviet, Remi et al (2022) Nature Communications, 13, (1).

Mental health and alcohol use among patients attending a post-COVID-19 follow-up clinic: a cohort study.

HRB Open Research, Broughan, John et al (2022) Early online. https://doi.org/10.12688/hrbopenres.13503.1

Associations of delay discounting and drinking trajectories from ages 14 to 22.

Fröhner, Juliane H et al (2022) Alcoholism, Clinical and Experimental Research, Early online. doi: 10.1111/acer.14799

Association between workplace absenteeism and alcohol use disorder from the National Survey on Drug Use and Health, 2015-2019.

Parsley, Ian C et al (2022) JAMA Network Open, 5, (3). doi: 10.1001/jamanetworkopen.2022.2954

Alcohol consumption trajectories over the Australian life course.

Leggat, Geoffrey et al (2022) Addiction, Early online. doi: 10.1111/add.15849

“You can be a hybrid when it comes to drinking”. The marketing and consumption of no and low alcohol drinks in the UK.

(2022) London: Institute of Alcohol Studies

The views of researchers on the alcohol industry's involvement in science: findings from an interview study.

McCambridge, Jim and Mitchell, Gemma (2022) European Addiction Research, Early online. pp. 1-8. https://doi.org/10.1159/000522603

Autistic traits and alcohol use in adolescents within the general population.

Pijnenburg, Lisa J et al (2022) European Child & Adolescent Psychiatry, Early online. https://doi.org/10.1007/s00787-022-01970-3

What are LGBTQ+ people’s experiences of alcohol services in Scotland? A qualitative study of service users and service providers.

Dimova, Elena et al (2022) Edinburgh: Scottish Health Action on Alcohol Problems.

Sexism free night – research report.

Plaza L et al (2022) Sexism Free Night European Project.

Illicit drug use in universities: zero tolerance or harm reduction? Debate paper 29.

Ozcubukcu, Arda and Towl, Graham (2022) Oxford: Higher Education Policy Institute.

Individual and combined association between prenatal polysubstance exposure and childhood risk of attention-deficit/hyperactivity disorder.

Garrison-Desany, et al (2022) JAMA Network Open, 5, (3).

Self-management interventions for reducing challenging behaviors among school-age students: a systematic review.

Smith, Tyler E (2022) Campbell Systematic Reviews, 18, (1).

European responses to the needs of people who experience homelessness and use drugs.

Pleace, Nicolas and Lloyd, Charlie (2020) Lisbon: EMCDDA

[Webpage] BCIHub: Your knowledge hub for behavioural and cultural insights into health.

University of Exeter's WHO Collaborating Centre for Culture and Health, WHO Regional Office for Europe, Behavioural and Cultural Insights Unit. (2022)

Effect of combination treatment with varenicline and nicotine patch on smoking cessation among smokers who drink heavily: a randomized clinical trial.

King, Andrea et al (2022) JAMA Network Open, 5, (3).

Cigarette taxation and neonatal and infant mortality: a longitudinal analysis of 159 countries.

Radó, Márta K et al (2022) PLOS Global Public Health, 2, (3).

Where next for the WHO Framework Convention on Tobacco Control?

Bialous, Stella and Da Costa E Silva, Vera Luiza (2022) Tobacco Control, 31, (2), pp. 183-186.

Understanding the long-term policy influence strategies of the tobacco industry: two contemporary case studies.

Hird, Thomas R et al (2022) Tobacco Control, 31, (2), pp. 297-307

Evolution of tobacco products: recent history and future directions.

O'Connor, Richard et al (2022) Tobacco Control, 31, (2), pp. 175-182.

Prevalence of Menthol and menthol capsule cigarette use among 11-16 year olds in Wales prior to a ban on characterizing flavors in cigarettes: findings from the 2019 Student Health and Wellbeing Survey.

Moodie, Crawford et al (2022) Nicotine & Tobacco Research, Early online. doi: 10.1093/ntr/ntac040

Closing the gaps in tobacco endgame evidence: a scoping review.

Puljević, Cheneal et al (2022) Tobacco Control, 31, (2), pp. 365-375.

Association of quarterly prevalence of e-cigarette use with ever regular smoking among young adults in England: a time-series analysis between 2007 and 2018.

Beard, Emma et al (2022) Addiction, Early online. doi: 10.1111/add.15838

Problematic gaming risk among European adolescents: a cross-national evaluation of individual and socio-economic factors.

Colasante, Emanuela et al (2022) Addiction, Early online. doi: 10.1111/add.15843

Families and gambling: a resource toolkit for working with families affected by gambling.

(2022) London: Adfam.

Helping families and friends negatively affected by gambling: policy and practice recommendations from Adfam’s research.

(2022) London: Adfam.

Harm as reported by affected others: a population-based cross-sectional Finnish Gambling 2019 study.

Lind, Kalle et al (2022) Addictive Behaviors, 129. doi: 10.1016/j.addbeh.2022.107263

Copyright © 2022 HRB National Drugs Library. All rights reserved.

The HRB National Drugs Library newsletter is a free subscriber-only monthly email newsletter offering relevant Irish and international news and information on alcohol and other drugs research. E-mail addresses provided for the purpose of subscribing to the newsletter will only be used by the library to distribute the requested information. The newsletter is published by the HRB National Drugs Library, Health Research Board. The library is staffed by qualified information professionals who handle a wide range of enquiries. Not sure what we can do for you? Email us and we will be happy to discuss your information needs.

This email was sent to [email protected] from [email protected]
Unsubscribe | Report Misuse | Receive in Plain Text